Addressing COVID-19 vaccine hesitancy

15Citations
Citations of this article
46Readers
Mendeley users who have this article in their library.

Abstract

Immunization programmes have been globally recognized as one of the most successful medical interventions against infectious diseases. Despite the proven efficacy and safety profiles of coronavirus disease 2019 (COVID-19) vaccines, there are still a substantial number of people who express vaccine hesitancy. Factors that influence vaccine decision-making are heterogenous, complex, and context specific and may be caused or amplified by uncontrolled online information or misinformation. With respect to COVID-19, the recent emergence of novel variants of concern that give rise to milder disease also drives vaccine hesitancy. Healthcare professionals remain one of the most trusted groups to advise and provide information to those ambivalent about COVID-19 vaccination and should be equipped with adequate resources and information as well as practical guidance to empower them to effectively discuss concerns. This article seeks to summarize the currently available information to address the most common concerns regarding COVID-19 vaccination.

Cite

CITATION STYLE

APA

Kassianos, G., Puig-Barberà, J., Dinse, H., Teufel, M., Türeci, Ö., & Pather, S. (2022). Addressing COVID-19 vaccine hesitancy. Drugs in Context. Bioexcel Publishing LTD. https://doi.org/10.7573/dic.2021-12-3

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free